There were no initial public offerings in the past week, but recent IPO performance continues to trend up. The 24 IPOs in 2015 now average +18%, including +5% after the first day, its highest point this year.
A few highlights from February 2015:
• 10 IPOs priced in February, down from 20 in 2014
• These returned 7.5% on average; ...read more
This past week, the set of small health IPOs that had been languishing on the IPO calendar either postponed or went public. • Two small health IPOs raised a combined $52 million • Two small health IPOs postponed indefinitely • Just one best-efforts IPO on the calendar...read more
Check-Cap, which is developing an ingestible imaging capsule to detect colorectal cancer, raised $12 million by offering 2 million units at $6, the low end of the range of $6 to $8.
The company commands a fully diluted market value of $61 million, less than half of its originally proposed diluted market value of $131 million. The company added warrants to the IPO in January and...read more
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could decline if the week ahead is similar to last week, which saw ...read more
US IPO Weekly Recap: No IPOs in final week of a challenging February
There were no initial public offerings in the past week, but recent IPO performance continues to trend up. The 24 IPOs in 2015 now average +18%, including +5% after the first day, its highest point this year. A few highlights from February 2015: • 10 IPOs priced in February, down from 20 in 2014 • These returned 7.5% on average; ...read more
US IPO Weekly Recap: Health IPOs go public or postpone ahead of a busy March
This past week, the set of small health IPOs that had been languishing on the IPO calendar either postponed or went public. • Two small health IPOs raised a combined $52 million • Two small health IPOs postponed indefinitely • Just one best-efforts IPO on the calendar...read more
Gulp: Imaging capsule maker Check-Cap prices IPO at $6, the low end of the range
Check-Cap, which is developing an ingestible imaging capsule to detect colorectal cancer, raised $12 million by offering 2 million units at $6, the low end of the range of $6 to $8. The company commands a fully diluted market value of $61 million, less than half of its originally proposed diluted market value of $131 million. The company added warrants to the IPO in January and...read more
Week ahead: 12 IPOs feature health care, holdovers and a $500 million health tech IPO
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could decline if the week ahead is similar to last week, which saw ...read more